About Berkeley HeartLab

“Approximately every 25 seconds, an American will have a coronary event.”
-2011 AHA Heart Disease & Stroke Update

Heart disease is the leading cause of death in the United States. Traditional guideline-based approaches (such as the Lipid Panel) do not always reveal underlying cardiometabolic issues that may expose an individual to high risk for a heart attack or stroke.

Berkeley HeartLab, now part of Quest Diagnostics, offers a solution that can help healthcare providers uncover an individual’s hidden risk. The proprietary test offering includes lipoprotein subfractionation analyses, advanced cardiovascular risk markers and genetic tests that can determine risk characteristics. The Berkeley HeartLab comprehensive approach improves risk characterization.

To address each individual’s unique needs, a personalized approach to cardiovascular disease management, the 4myheart Program, is also available at no additional cost or obligation. Clinical Educators help individuals in the 4myheart Program adopt treatment plans developed by their clinicians based on Berkeley HeartLab test results, current lifestyle, health history and readiness to change.

Learn more about Berkeley HeartLab by visiting bhlinc.com or contacting your BHL representative.

References
1 Roger et al. Heart Disease and Stroke Statistics--2011 Update : A Report From the American Heart Association. Circulation 2011. e18-e209.

Berkeley HeartLab

< Back to previous page